Need answers or support?  Call 866-228-4673

Medical Directors

Joshua B. Rubin, M.D., Ph.D 

Scientific Advisory Committee Chair


 Dr. Rubin is the Associate Professor of Pediatrics, Co-Director of Pediatric Neuro-Oncology, Co-Leader of the Cancer and Developmental Biology program at the Washington University School of Medicine in St. Louis. 

He received his Bachelor of Science degree from Yale University in 1982, followed by his M. Sc and, Ph.D.in neuroscience and his M.D. at the Albert Einstein College of Medicine in 1994.

He was a resident at the Children's Hospital of Harvard University from 1994 to 1997 and a fellow in hematology/oncology at Dana Farber Cancer Institute from 1997-2000.

He is licensed by the state of Missouri and board certified by the American Board of Pediatrics, sub-board of Pediatric Hematology/Oncology.

He was received numerous honors including: Alpha Omega Alpha in 1993, the NICHD Scholar of the Child Health Research Center for Excellence in developmental biology at Washington University School of Medicine from 2003-2006 as well as the Hyundai Scholar in 2008.

Dr. Jeffrey C. Allen

Medical Director

Dr. Allen is one of the original founders of the Children's Brain Tumor Foundation. He is currently the Director of Pediatric Neuro-Oncology at New York University Medical Center. He graduated from Harvard Medical School in 1969.

Dr. Allen has developed two pediatric neuro-oncology programs in Manhattan in

order to foster the best multidisciplinary care for children with brain and spine conditions. The first program was at Memorial Sloan-Kettering Cancer Center (1976-86) and the second at NYU Medical Center (1986-96). Dr. Allen has also devoted considerable effort to advance basic research in neuro-oncology. He was the Principal Investigator of an NIH funded Program Project which established a Brain Tumor Research Center at NYU Medical Center (1992-95) as well as a Brain Tumor Bank and Patient Database. From 1995 to 2004 he was the Chairman of the Pediatric Neurology Department at Beth Israel Medical Center-Singer Division in New York City.

He has held several leadership positions in brain tumor studies of the Children's Cancer Study Group. He is a member of the Child Neurology Society and the American Academy of Neurology. He has trained over 15 pediatric neuro-oncology fellows who have gone on to have productive academic careers. He achieved the rank of tenured professor in Neurology at NYU Medical Center and has published extensively, primarily in the field of pediatric neuro-oncology.

Dr. Jonathan Finlay

Medical Director

Born in 1948 in Manchester, England, Dr. Finlay received his undergraduate and medical school education at the University of Birmingham, graduating in 1973. He undertook residency training in Pediatrics in Birmingham, ending with training in Pediatric Oncology at the Christie Hospital and Holt Radium Institute, Manchester, before moving to the United States in 1976. He undertook Fellowship training, first in Pediatric Immunology (1976-78) and then in Pediatric Hematology and Oncology (1978-80) at the University of Wisconsin-Madison.

During his first staff position (Assistant Professor of Pediatrics) at Stanford University (1980-82), Dr. Finlay initiated his now long-standing interest in and commitment to the problems of children with brain tumors. Upon return to Madison, Wisconsin in 1982, Dr. Finlay established the Mid-West Pediatric Brain Tumor Center, attempting to coordinate the care of children with brain tumors across the region of Wisconsin, Northern Illinois and Eastern Iowa.

In 1985, Dr. Finlay was appointed as Chairman of the Brain Tumor Strategy Group of the nation-wide Children's Cancer Group (CCG). Representing over half of all pediatric cancer centers in the United States, he oversaw the development of national treatment programs to improve the outcome for children with brain tumors. He held this position until 1992, and continues as a member of the Steering Committee for the CCG Brain Tumor Strategy Group.

Dr. Finlay moved to the Children's Hospital of Philadelphia in 1987, as a Senior Physician and Associate Professor of Pediatrics of the University of Pennsylvania, continuing to develop and conduct innovative therapeutic programs for children with brain tumors, focusing on the use of very high doses of drug treatment (chemotherapy) followed by 'rescue' with the patients' own bone marrow ("bone marrow transplants").

In 1989, Dr. Finlay moved to New York as Vice Chairman of the Department of Pediatrics at Memorial Sloan-Kettering Cancer Center (MSKCC) and Associate Professor of Pediatrics at Cornell University Medical College. During the ensuing eight years, the Pediatric Brain Tumor Program at MSKCC became not only one of the largest in the United States, but additionally a leading center during that time period for the chemotherapeutic treatment of childhood brain tumors, with the development of innovative programs, for example, (1) to avoid the use of radiation therapy for children less than six years of age newly diagnosed with malignant brain tumors, (2) to treat a rare family of brain tumors, known as germ cell tumors, in an international study (involving Argentina, Australia, the United Kingdom, Canada and the U.S.) with chemotherapy alone, and (3) to treat otherwise incurable brain tumors that have recurred following initial treatments with very high dose chemotherapy and marrow rescue.

In October 1997, Dr. Finlay relocated, along with several members of his pediatric brain tumor team, to New York University Medical Center, where he became the Director of the newly established Division of Pediatric Oncology and of the Hassenfeld Center for Cancer and Blood Diseases of Childhood, and a tenured Professor of Pediatrics at New York University. In 2002, Dr. Finlay was awarded the Julie and Edward J. Minskoff Chaired Professorship in Pediatrics (Neuro-oncology) at New York University. During his six years at New York University, the innovative treatment programs developed at MSKCC continued and expanded under his direction.

In October of 2003, Dr. Finlay moved to California as the Director of the Neural Tumors Program at Childrens Hospital Los Angeles and Professor of Pediatrics at the Keck School of Medicine, University of Southern California. This program is one of the largest brain tumor programs for children in North America.

Dr. Finlay is internationally recognized as a leading authority in the management of children with brain tumors. Over the last 25 years, Dr. Finlay has authored or co-authored 125 peer reviewed publications in leading medical journals and 65 review articles and book chapters. Since 1985 he had delivered over 175 invited lectures world-wide, mainly on childhood brain tumors, through Visiting Professorships or national/international medical conferences. He has been cited in the recent editions of "The Best Doctors in America" (Woodward & White) and cited in several "New York" magazine issues on "Best Doctors in New York".

Since 1982, Dr. Finlay has mentored over 50 undergraduate students, medical students, medical residents and fellows in clinical research projects. Several of these individuals now direct brain tumor programs throughout the world.

Dr. Finlay has served on the Editorial Boards of several leading medical journals, and on the Advisory Boards and/or as Medical Director of several national philanthropic foundations devoted to childhood cancer in general and childhood brain tumors in particular.

Dr. Finlay is himself a long term survivor of disseminated, recurrent testicular cancer. He is married to Adriana Rodrigues Da Cunha Finlay, formerly of Uberaba, Brazil. They have two Yorkshire terriers. Favored past-times include the movies, cooking, fine wines, exotic travel, and the postal history of Lombardy and Venetia from the Battle of Waterloo until the Unification of Italy!

 

Share/Save

©2009 Children's Brain Tumor Foundation.    274 Madison Avenue Suite 1004 New York, NY 10016    (866) 228-4673    info@cbtf.org

Privacy Policy   |   Site Map
 

X
Loading